# FDA Inspection 1238535 - Vitalant - May 09, 2024

Source: https://www.keypedia.com/records/fda_inspections/vitalant/e3c79028-63ce-4c27-ba30-240b85dcf4e9
Source feed: FDA_Inspections

> FDA Inspection 1238535 for Vitalant on May 09, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1238535
- Company Name: Vitalant
- Inspection Date: 2024-05-09
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1100795 - 2019-07-30](https://www.keypedia.com/records/fda_inspections/vitalant/a8d4f26e-2721-493c-80d1-012a69be0f1b)
- [FDA Inspection 1000614 - 2017-01-10](https://www.keypedia.com/records/fda_inspections/vitalant/2b78bc74-ce40-4f09-9bc9-f477ebfca3cd)
- [FDA Inspection 910116 - 2015-01-15](https://www.keypedia.com/records/fda_inspections/vitalant/d4aa5cc6-a8b7-49d6-8586-81536703f88b)
- [FDA Inspection 810119 - 2012-11-08](https://www.keypedia.com/records/fda_inspections/vitalant/3dc365cf-9d39-4bd9-aded-60fde428b898)
- [FDA Inspection 699289 - 2010-11-23](https://www.keypedia.com/records/fda_inspections/vitalant/1c45e785-c856-4c61-8704-52cecd1a779f)

Company: https://www.keypedia.com/companies/vitalant/a5d0608c-c3d7-4345-9190-a4a9f391b5c7

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d